TrialCancer2025

Efficacy of losartan plus modified FOLFIRINOX versus modified FOLFIRINOX in advanced pancreatic cancers: A randomized clinical trial (AFPAC Study).

Anant Ramaswamy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.